aptamer truncation
Info Center
  • Custom Aptamer Discovery & Development: A Practical, Science-First Guide from Target Definition to Validated Candidates

    CUSTOM APTAMER DISCOVERY & DEVELOPMENT is the process of creating target-specific single-stranded DNA or RNA aptamers—short nucleic acids that fold into 3D shapes capable of binding proteins, small molecules, cells, vesicles, or other targets with antibody-like selectivity. Most custom programs rely on SELEX (Systematic Evolution of Ligands by EXponential enrichment), then refine “hits” into robust, application-ready binders through sequencing-driven analysis and post-selection optimization.    1) What Aptamers Are (and Why They’re Used)   Aptamers are typically ~15–90 nucleotides long and can be engineered to bind targets across a wide size range (from small molecules to whole cells). They’re attractive because they are chemically synthesized (batch-to-batch consistency), can be readily labeled (fluorophores, biotin, etc.), and are generally thermally stable and re-foldable—features that often simplify assay development and manufacturing.  Common aptamer use cases Diagnostics & biosensors (capture probes, signal transducers, point-of-care formats)  Targeted delivery & therapeutics research (cell-directed binding, payload delivery concepts)  Affinity purification & analytical workflows (pull-downs, enrichment, separations)      2) The Core Workflow in Custom Aptamer Discovery   A custom program is best thought of as a pipeline with four linked decisions: target format → selection strategy → analytics → optimization. Step A — Target Definition and “Bindability” Planning…

    2025-12-07
  • Completion of SELEX: What It Means, How to Recognize It, and What Happens Next

    “Completion of SELEX” refers to the point in the Systematic Evolution of Ligands by EXponential enrichment (SELEX)workflow where iterative selection rounds have produced an enriched nucleic-acid pool (DNA or RNA) that contains high-affinity, high-specificity binding sequences (aptamers) for a defined target, and further rounds provide diminishing improvements. In practical terms, completion is less a single universal round number and more a decision point supported by enrichment evidence, performance metrics, and downstream readiness.  1) SELEX in One Picture (Why “Completion” Exists at All)   SELEX is an iterative evolutionary loop performed in vitro: Start with a diverse library (randomized nucleic-acid sequences). Bind the library to a target (protein, small molecule, cell surface, complex mixture, etc.). Partition: separate binders from non-binders (the critical “selection” step). Elute and amplify the binders (PCR for DNA; RT-PCR for RNA). Repeat with increasing stringency (less target, harsher washes, counter-selection, etc.).    “Completion” matters because every additional round costs time, introduces amplification bias, and can over-enrich “fast amplifiers” rather than “best binders.” Modern practice treats completion as an optimization endpoint, not a ritual number of rounds.  2) What “Completion of SELEX” Typically Means (Conceptual Definition)   A common knowledge-centered definition is: The pool has converged toward one…

    2025-12-07
  • SELEX Aptamer Selection: A Practical, Science-First Guide to How Aptamers Are Discovered and Optimized

    What “SELEX Aptamer Selection” Means   SELEX stands for Systematic Evolution of Ligands by Exponential Enrichment. In plain terms, SELEX aptamer selectionis an iterative laboratory workflow that starts with a huge pool of random DNA or RNA sequences and repeatedly enriches the fraction that binds a chosen target with high affinity and specificity. The “winners” are called aptamers—single-stranded nucleic acids that fold into 3D shapes capable of target recognition, often compared to “chemical antibodies,” but made by selection and synthesis rather than immune systems.  Core Concept: Darwinian Evolution in a Test Tube   SELEX is essentially variation + selection + amplification: Variation: Begin with a randomized oligonucleotide library (often ~10^13–10^16 unique sequences). Selection: Expose the library to the target; keep sequences that bind. Amplification: PCR (or RT-PCR for RNA workflows) amplifies binders to create the next-round pool. Increasing stringency: Each round tightens conditions (less target, harsher washes, more competitors), enriching the best binders over multiple cycles.   Most conventional SELEX workflows run multiple rounds (often roughly 6–15) before candidates are sequenced and characterized.  The Classic SELEX Workflow (Step-by-Step, With the “Why”)   1) Library design (the “starting universe”)   A typical library contains: A random region (e.g., N30–N60) that can…

    2025-12-07